Abstract
Aim: Peptide-based vaccines are designed to carry the minimum required antigen to trigger the desired immune responses; however, they are usually poorly immunogenic and require appropriate delivery system. Results: Peptides, B-cell epitope (J14) derived from group A streptococcus M-protein and universal T-helper (PADRE) epitope, were conjugated to a variety of linear and branched polyacrylates. All produced conjugates formed submicron-sized particles and induced a high level of IgG titres in mice after subcutaneous immunization. These polymer-peptide conjugates demonstrated high opsonization capacity against group A streptococcus clinical isolates. Conclusion: We have successfully demonstrated that submicron-sized polymer-peptide conjugates were capable of inducing strong humoral immune responses after single immunization.
| Original language | English |
|---|---|
| Pages (from-to) | 601-609 |
| Number of pages | 9 |
| Journal | Therapeutic Delivery |
| Volume | 7 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - Sept 2016 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- clinical isolates
- group A streptococcus
- nanoparticles
- opsonization
- peptide vaccine
- polyacrylates
- polymer-peptide conjugate
- single immunization
- vaccine delivery
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver